Inactive Instrument

News Cangene Corporation

Equities

Cangene Corporation : 12/13/2013 Cangene Reports First Quarter 2014 Results and Election of Directors	13-12-13	PU
Cangene Corporation : 12/11/2013 Cangene To Be Acquired By Emergent BioSolutions For US$222 Million	13-12-11	PU
Cangene Corporation : FDA lifts clinical hold on Cangene's hemophilia compound IB1001	13-07-29	PU
Cangene Corporation : Cangene Reports Third Quarter 2013 Results	13-06-05	PU
Cangene Corp : Further Senior Management Change at Cangene	12-04-11	PU
Cangene Corp : Cangene Names John A. Sedor as President and Chief Executive Officer	11-08-16	PU
CANGENE : ANNOUNCES THIRD QUARTER FINANCIAL RESULTS FOR FISCAL 2011	11-06-13	PU
CANGENE : BARDA EXERCISES OPTIONS WITH CANGENE WORTH US$61 MILLION UNDER BOTULISM ANTITOXIN SUPPLY CONTRACT	11-06-03	PU

No results for this search